PMDA publishes Remote Inspection Guidance
The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has published an English version of its "Procedure for Remote Inspection as a part of compliance inspection on drugs and regenerative medical products".
The document describes the concrete procedure of a remote inspection, clarifies how to proceed with the necessary documents and reflects expectations to video conferencing systems.
The PMDA sets a clear time point for document requests: "by 10:00 am, 13 business days before the main-inspection", the auditee ("applicant") should be informed by the inspector. Then the applicant has three days to provide the documents. This leads to a so-called Pre-Inspection, in which the inspector checks the documents. In the main inspection, which is then conducted as a video conference, the inspector can request further documents, but will mainly deal with concerns and possible questions about the documents already requested. How all these documents can be presented is explained in detail in the document.
The applicant is responsible for the costs, quality, set-up and security of the data transmission and the video conference. This is also described in detail.
Related GMP News
24.07.2024FDA Warning Letter to a Manufacturer of an Athlete Muscle Maintenance Creme
24.07.2024FDA describes detailed CAPA Procedure in Warning Letter
17.07.2024Congressional Scrutiny on FDA's Foreign Inspection Program puts Pressure on Agency
19.06.2024More FDA Inspections again - also in the EU?
12.06.2024GMP Problems with critical Medicinal Products - what now?
15.05.2024Lack of Quality Oversight: EU Non-Compliance Report issued to Omeprazole Manufacturer